Deerfield Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,555,871	Closed	-$5.87M	–	129
2024 Q4	$5.87M	Hold	3,555,871	–	–	0.11%	69
2024 Q3	$12.4M	Hold	3,555,871	–	–	0.19%	64
2024 Q2	$11.7M	Buy	3,555,871 +1,365,463	+62%	+$5.98M	0.19%	64
2024 Q1	$16.1M	Buy	+2,190,408	New	+$13.6M	0.28%	59
2021 Q4	–	Sell	-362,000	Closed	-$21.5M	–	134
2021 Q3	$21.5M	Buy	362,000 +58,000	+19%	+$4.55M	0.42%	66
2021 Q2	$26.4M	Hold	304,000	–	–	0.47%	71
2021 Q1	$25.1M	Buy	+304,000	New	+$29.1M	0.53%	66
2020 Q4	–	Sell	-668,067	Closed	-$41.5M	–	28
2020 Q3	$26.7M	Sell	668,067 -245,708	-27%	-$8.58M	0.65%	50
2020 Q2	$31.4M	Sell	913,775 -703,218	-43%	-$21M	0.91%	36
2020 Q1	$35.9M	Sell	1,616,993 -385,612	-19%	-$9.75M	1.14%	29
2019 Q4	$39.2M	Buy	2,002,605 +49,708	+3%	+$789K	1.25%	28
2019 Q3	$30.3M	Buy	1,952,897 +250,000	+15%	+$4.79M	1.24%	24
2019 Q2	$34.6M	Hold	1,702,897	–	–	1.24%	23
2019 Q1	$29.9M	Buy	1,702,897 +48,032	+3%	+$758K	1.15%	28
2018 Q4	$21.2M	Buy	1,654,865 +481,248	+41%	+$6.71M	0.85%	42
2018 Q3	$19.1M	Buy	+1,173,617	New	+$13.9M	0.68%	49